SCHEMBL4178519

SCHEMBL4178519

CN1CCN(c2cccc(OCc3ccccc3)c2)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.63
MAPT P10636 1/20 0.63
MAPK1 P28482 1/20 0.63
KMT2A Q03164 1/20 0.63
ESR2 Q92731 1/20 0.63
TAAR1 Q96RJ0 1/20 0.63
AGXT P21549 1/20 0.61
HRH3 Q9Y5N1 2/20 0.59
HTR6 P50406 2/20 0.58
ALDH1A1 P00352 1/20 0.57
GAA P10253 1/20 0.57
TSHR P16473 1/20 0.57
NPC1 O15118 1/20 0.56
TP53 P04637 1/20 0.56
RAB9A P51151 1/20 0.56
MAOB P27338 3/20 0.54
GRM5 P41594 1/20 0.52
MAP4K1 Q92918 1/20 0.52
ADRA2C P18825 2/20 0.51
HRH4 Q9H3N8 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8322225 0.86 MAOB (0.58) AGXTHRH3ALDH1A1TSHRMAOB
SCHEMBL13202898 0.85 RAB9A (0.67) USP2MAPTMAPK1KMT2AESR2
SCHEMBL3103344 0.85 MAOB (0.57) AGXTHRH3ALDH1A1TSHRMAOB
SCHEMBL4671546 0.82 ADRB1 (0.59) HTR6TP53MAOBGRM5ALOX5
SCHEMBL1263059 0.82 AGXT (0.61) MAPK1KMT2AAGXTALDH1A1TSHR
SCHEMBL4671542 0.82 ALOX5 (0.54) USP2MAPTMAPK1KMT2AESR2
SCHEMBL6350404 0.82 NPC1 (0.52) USP2MAPTMAPK1KMT2AESR2
SCHEMBL22955186 0.82 NPC1 (0.52) USP2MAPTMAPK1KMT2AESR2
SCHEMBL12251546 0.81 ADRA2C (0.57) MAPTKMT2AAGXTALDH1A1TSHR
Hydrochloric Acid SCHEMBL1532961 0.81 ADRB1 (0.57) HTR6MAOBGRM5ALOX5HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090069315-A1 Use of Pyrazolo(1,5A)Pyrimidin-7-YL Amine Derivatives in the Treatment of Neurological Disorders SIVASANKARAN RAJEEV 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069315-A1 Use of Pyrazolo(1,5A)Pyrimidin-7-YL Amine Derivatives in the Treatment of Neurological Disorders EPHA5, EPHA7, EPHA1 USP2 4709/4885MAPT 582/4885MAPK1 1136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.